Skip to main content
Article thumbnail
Location of Repository

Rate of improvement during and across three treatments for panic disorder with or without agoraphobia:Cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined

By Franske J. Van Apeldoorn, Wiljo J. P. J. Van Hout, Marieke E. Timmerman, Peter Paul A. Mersch and Johan A. den Boer


<p>Background: Existing literature on panic disorder (PD) yields no data regarding the differential rates of improvement during Cognitive Behavioral Therapy (CBT), Selective Serotonin Reuptake Inhibitor (SSRI) or both combined (CBT+SSRI).</p><p>Method: Patients were randomized to CBT, SSRI or CBT+SSRI which each lasted one year including three months of medication taper. Participating patients kept record of the frequency of panic attacks throughout the full year of treatment. Rate of improvement on panic frequency and the relationship between rate of improvement and baseline agoraphobia (AG) were examined.</p><p>Results: A significant decline in frequency of panic attacks was observed for each treatment modality. SSRI and CBT+SSRI were associated with a significant faster rate of improvement as compared to COT. Gains were maintained after tapering medication. For patients with moderate or severe AG, CBT+SSRI was associated with a more rapid improvement on panic frequency as compared to patients receiving either mono-treatment.</p><p>Limitations: Frequency of panic attacks was not assessed beyond the full year of treatment. Second, only one process variable was used.</p><p>Conclusions: Patients with PD respond well to each treatment as indicated by a significant decline in panic attacks. CBT is associated with a slower rate of improvement as compared to SSRI and CBT+SSRI. Discontinuation of SSRI treatment does not result in a revival of frequency of panic attacks. Our data suggest that for patients without or with only mild AG, SSRI-only will suffice. For patients with moderate or severe AG, the combined CBT+SSRI treatment is recommended. (C) 2013 Elsevier B.V. All rights reserved.</p>

Topics: Panic disorder, Agoraphobia; Randomized controlled trials; Cognitive behavioral therapy; Drug treatment; Panic attacks; Rate of improvement; Process study; ANXIETY; TRIAL; PHARMACOTHERAPY; PSYCHOTHERAPY; COMBINATION; FLUVOXAMINE; IMIPRAMINE; PLACEBO; CBT
Year: 2013
DOI identifier: 10.1016/j.jad.2013.04.012
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.